Fenwal Didn't Infringe Blood Centrifuge Patent: Judge

Law360, New York (September 15, 2011, 6:13 PM EDT) -- A Massachusetts federal judge on Tuesday ended a long-running patent infringement dispute over blood processing technology, finding that Fenwal Inc.’s products did not infringe a Haemonetics Corp. patent.

U.S. District Judge Nathaniel M. Gorton granted Fenwal’s motion for summary judgment in both of the suits Haemonetics lodged against Fenwal in 2005 and 2009 seeking to protect the rights of U.S. Patent Number 6,705,983.

“Fenwal’s products do not infringe the ‘983 patent, either literally or under the doctrine of equivalents,” Judge Gordon said in his order....
To view the full article, register now.